Cargando…
Design, Synthesis, and Biological Evaluation of a Small-Molecule PET Agent for Imaging PD-L1 Expression
Immunotherapy blocking programmed cell death protein 1/programmed death ligand 1 (PD-1/PD-L1) pathway has achieved great therapeutic effect in the clinic, but the overall response rate is not satisfactory. Early studies showed that response to treatment and overall survival could be positively relat...
Autores principales: | Xu, Liang, Zhang, Lixia, Liang, Beibei, Zhu, Shiyu, Lv, Gaochao, Qiu, Ling, Lin, Jianguo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9968138/ https://www.ncbi.nlm.nih.gov/pubmed/37259361 http://dx.doi.org/10.3390/ph16020213 |
Ejemplares similares
-
Development of a radiolabeled site-specific single-domain antibody positron emission tomography probe for monitoring PD-L1 expression in cancer
por: Chen, Yinfei, et al.
Publicado: (2022) -
Synthesis and Biological Evaluation of Small Molecules as Potential Anticancer Multitarget Agents
por: Pla-López, Alberto, et al.
Publicado: (2022) -
Drug Design, Synthesis and Biological Evaluation of Heterocyclic Molecules as Anti-Inflammatory Agents
por: Savjani, Jignasa, et al.
Publicado: (2022) -
A fluorine-18 labeled radiotracer for PET imaging of γ-glutamyltranspeptidase in living subjects
por: Gao, Dingyao, et al.
Publicado: (2021) -
Design and Biological Evaluation of Small-Molecule PET-Tracers for Imaging of Programmed Death Ligand 1
por: Krutzek, Fabian, et al.
Publicado: (2023)